Loading clinical trials...
Loading clinical trials...
Valacyclovir for the Suppression of HSV-2 Viral Shedding in HSV-2 Seropositive Individuals With No History of Symptomatic GH
Conditions
Interventions
Valaciclovir
Placebo
Locations
17
United States
GSK Investigational Site
Carmichael, California, United States
GSK Investigational Site
Davis, California, United States
GSK Investigational Site
Riverside, California, United States
GSK Investigational Site
Sacramento, California, United States
GSK Investigational Site
Fort Wayne, Indiana, United States
GSK Investigational Site
Indianapolis, Indiana, United States
Start Date
March 29, 2005
Primary Completion Date
January 10, 2006
Completion Date
January 10, 2006
Last Updated
February 12, 2018
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions